Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Plasmonic biosensors with artificial antibodies

a) TEM image of gold nanorods; b) electric field distribution at the extinction maximum of the longitudinal SPR band; and c) illustration of imprinted nanorod with siloxane copolymer preferentially grown at the ends.
a) TEM image of gold nanorods; b) electric field distribution at the extinction maximum of the longitudinal SPR band; and c) illustration of imprinted nanorod with siloxane copolymer preferentially grown at the ends.

Abstract:
The use of localized surface plasmon resonance (SPR) as a platform in biological sensing holds immense promise in delivering devices with superior sensitivity to those of competing technologies. Until now, a major drawback has been that the production of plasmonic biosensors required the use of natural antibodies, making the process expensive and time-consuming. An important step toward overcoming this problem has recently been made, with researchers at Washington University reporting a novel plasmonic biosensor with ‘artificial' antibodies.

Plasmonic biosensors with artificial antibodies

Germany | Posted on November 7th, 2012

The biosensor developed is based on very small changes in the SPR spectrum of gold nanorods upon selective binding of a target biomolecule (binding changes the refractive index surrounding the nanorod and thereby shifts the plasmon band). In order to achieve high selectivity, the researchers used the method of macromolecular imprinting to incorporate target species—as a proof-of-concept, several different proteins were used—into a polymer network in close vicinity (several nanometers) to the nanorod. Removal of the target leaves behind a cavity in the polymer, which acts as a ‘lock and key' receptor enabling selective binding of the analyte.

In order to attain maximal sensitivity, it is imperative that the polymer and the molecularly imprinted species are concentrated at the ends of the nanorod. This requirement owes to the fact that the electric field surrounding the nanorod is nonuniform, with the longitudinal resonance being stronger and more sensitive than the transverse (the electric field distribution of the longitudinal resonance is shown in figure panel (b)). This was achieved with the help of a surfactant (CTAB), which is known to adsorb preferentially at the sides of the nanorod. Specific chemicals employed to form a bridge between the nanorod and the polymer precursors were then able to interact preferentially with thiol groups on the ends of the nanorod due to the lower surfactant concentration. The result after polymerisation: a peanut shaped polymer-nanorod with the majority of the polymer and reversible template inclusions (i.e., artificial antibodies) at the ends where the SPR is most sensitivly affected by analyte binding (see figure panel (c)).

To demonstrate the viability of their biosensor in a real-world system, the researchers successfully detected recombinant human neutrophil gelatinase-associated lipocalin (NGAL), a urinary biomarker of acute kidney injury, with detection limits lower than those of conventional analytical techniques. Although emulating the performance of natural antibodies does remain a challenge, the authors suggest ways this could be achieved, meaning we are likely to hear a lot more about these novel biosensors in the near future.

####

For more information, please click here

Copyright © Wiley-VCH Materials Science Journals

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Link to the original paper on Wiley Online Library:

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Sensors

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Groundbreaking precision in single-molecule optoelectronics August 16th, 2024

Discoveries

Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project